U.S. Practice Management Systems Market Size, Revenue, Future Growth Insights And Business Analysis

The U.S. practice management systems market size is expected to reach USD 13.3 billion by 2027, registering a CAGR of 10.2% over the forecast period, according to a new report by Grand View Research, Inc. Demand for practice management system is growing due to increasing pressure to curb healthcare costs and changing dynamics of hospital/healthcare settings. Increasing focus on implementing cost-effective, quality care will further boost the market growth.

Political instability, economic stress, and lack of proactive initiatives are exerting adverse effects on the healthcare funding. Despite significant healthcare-related funding and insurance programs, there has been a constant rise in healthcare cost in U.S., thus affecting healthcare providers. The healthcare expenditure in U.S. was approximately 2.4 times higher than the global average in 2015 and is anticipated to increase by 68.0% in the next 10 years.

With the help of practice management systems, healthcare providers are able to offer right treatment at effective price, thus reducing treatment costs. Some of the prominent companies in the market are Henry Schein MicroMD; Allscripts Healthcare Solutions, Inc.; AdvantEdge Healthcare Solutions, Inc.; Cerner Corporation; GE Healthcare; and McKesson Corporation.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/us-practice-management-systems-market

Further key findings from the study suggest:

• Changing dynamics of hospital/healthcare settings and development and sale of value-added services are driving the market
• The integrated product segment captured the largest market share in 2019 due to benefits, such as enhanced efficiency and communication across various departments and reduced administrative and medical errors
• Software held the largest revenue share in the component segment in 2019 owing to technological advancement and new product launches
• Cloud-based practice management solutions is expected to show fastest growth over the forecast period owing to advantages such as ready availability of information even in remote locations, higher reliability, and faster processing
• Physician back office dominated the end-user segment in the market in 2019 due to growing adoption of this system in the physician offices
• Increasing focus of the Association of American Medical Colleges toward increasing number of physicians and healthcare facilities across the region is expected to drive the market growth
• Key companies in the U.S. practice management systems market include Henry Schein MicroMD; Allscripts Healthcare Solutions, Inc.; AdvantEdge Healthcare Solutions, Inc.; Cerner Corporation; GE Healthcare; and McKesson Corporation

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/us-practice-management-systems-market/request/rs1

Grand View Research has segmented the U.S. practice management systems market on the basis of product, component, delivery mode, and end user:

U.S. Practice Management Systems Product Outlook (Revenue, USD Million, 2016 - 2027)

• Integrated
• Standalone

U.S. Practice Management Systems Component Outlook (Revenue, USD Million, 2016 - 2027)

• Software
• Services

U.S. Practice Management Systems Delivery Mode Outlook (Revenue, USD Million, 2016 - 2027)

• On-premise
• Web-based
• Cloud-based

U.S. Practice Management Systems End-user Outlook (Revenue, USD Million, 2016 - 2027)

• Physician Back Office (Solo practitioners)
• Hospitals (Group practitioners)
• Pharmacies
• Diagnostic Laboratories
• Other Settings

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Korea Medical Aesthetics Market Business Growth, Development Factors, Applications, And Future Prospects 2027

The Korean medical aesthetics market size is expected to reach a value of USD 4.4 billion by 2027, expanding at a CAGR of 13.3%, according to a new report by Grand View Research, Inc. Korea is known as the plastic surgery capital of the world. Korea is one of the highly populated countries in the world. The major factors propelling the market are increasing desire for beauty, the rise of medical tourism, the influence of K-pop beauty, and technological advancement.

Appearance and beauty are institutionalized in the culture of Korea. The number of both non-invasive and non-invasive surgeries is high in Korea. Eyelid surgery is the most popular surgery as Koreans have monolid eyes. Monolid eyes are those eyes that have no crease on the eyelid. In addition, eyelid surgery is cheaper and has a shorter recovery time in comparison to other surgeries. Initially, Korea was known to have more facial surgeries. However, other procedures such as body contouring, lifting, Botox, and fillers are gaining popularity owing to easy access to non-invasive surgeries. Also, the entry barrier for performing these surgeries is low as anyone with a medical license is permitted to perform these surgeries. Korean men are also undergoing aesthetic procedures such as anti-aging, jaw surgeries, facial contouring, and blepharoplasty.

With the rising geriatric population in Korea, many people above the age of 40 are undergoing aesthetic treatment in order to look younger. Apart from astounding invasive and non-invasive procedures, Korea is known for innovating and developing new minimally invasive methods. For instance, Blue Rose thread facelifts. In this procedure, a series of self-dissolving threads are inserted near the hairline to tighten the skin.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/korea-medical-aesthetics-market

Korea Medical Aesthetics Market Report Highlights

• The non-invasive procedures segment dominated the market in 2018 and is expected to register the fastest CAGR over the forecast period. The rise in the number of men and women wanting to improve their aesthetic appearance has been fueling the demand for non-invasive procedures
• Eyelid Surgery held the largest share in the market, owing to factors such as inexpensive procedure and quick recovery time
• Botox injections dominated the market for medical aesthetics owing to the increasing demand for anti-aging treatment and the urge to look younger
• Key players of the market include Medytox; BioPlus Co., Ltd.; Daewoong Pharma; Cynosure (Hologic, Inc); Johnson and Johnson; Galderma S.A.; Alma Lasers; Allergan, Inc.; and Lutronic.

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/korea-medical-aesthetics-market/request/rs1

Korea Medical Aesthetics Market Segmentation

Grand View Research has segmented the Korea medical aesthetics market on the basis of procedure type:

Korea Medical Aesthetics Procedure Type Outlook (Revenue, USD Million, 2016 - 2027)

• Invasive Procedure
• Breast augmentation
• Liposuction
• Nose reshaping
• Eyelid Surgery
• Tummy tuck
• Others
• Non-invasive Procedure
• Botox injections
• Soft tissue fillers
• Chemical peel
• Laser hair removal
• Microdermabrasion
• Others

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Agricultural Biotechnology Market Size Is Projected To Reach $161.45 Billion By 2025

The global agricultural biotechnology market size is expected to reach USD 161.45 billion by 2025 growing at a CAGR of 7.07%, according to a new report by Grand View Research, Inc. Advent of unique genetic resources and genome modification tools is anticipated to enhance understanding of plant biology over the coming years. Additionally, a rise in demand for biofuel owing to depletion of conventional fuel is further projected to propel the market growth.

Penetration of genetic engineering tools has been recognized as a solution to overcome the pitfalls of conventional vaccine production. Genetically engineered vaccines have the potential of transforming the vaccine development scenario in the future. These products are continuously assessed by vaccine developing companies to understand the significance of recombinant vaccines in clinical as well as economical aspects which has made significant contributions to the revenue generated by vaccine development application segment in 2018.

Development of transgenic livestock is expected to immensely impact the improvement of nutrition, human health, animal welfare, reducing diseased livestock, and enhancing environmental protection. Moreover, genetic modification carried out in stem cells, livestock, and others are attributed to result in high-quality food and more yield from livestock. Some of the frequently adopted techniques for the development of transgenic animals include recombinant retroviruses, pronuclear Injection, sperm-mediated DNA transfer, embryonic stem cells, germ cell transplantation, and nuclear transfer “Cloning”.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/agricultural-biotechnology-market

Further key findings from the study suggest:

• Transgenic crops & animals segment accounted for the highest revenue generated in 2018 and is anticipated to maintain this trend throughout the forecast period
• Vaccine development segment is set to grow at the fastest pace from 2019-2025
• Agricultural biotechnology for plants has dominated with respect to market share and is projected to maintain its dominance throughout the forecast period
• Agricultural biotechnology for animals is the fastest growing organism type segment from 2019-2025
• North America is the leading regional market due to the high penetration of novel biotechnology tools
• In addition, a number of public-private partnerships has grown significantly in this region. These initiatives allow the development and maintenance of public infrastructure, agriculture, and healthcare programs in North America
• Asia Pacific is projected to be the fastest-growing regional market owing to supportive climatic conditions in different countries, which allows multiple growing seasons in a single year
• A robust network of local agricultural biotechnology manufacturers has significantly contributed to the revenue generated by Asia Pacific
• Some of the key participants in agricultural biotechnology market are KWS SAAT SE & Co. KGaA, Corteva, MITSUI & CO., LTD, Evogene Ltd., Valent BioSciences LLC, and Bayer AG among others

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/agricultural-biotechnology-market/request/rs1

Grand View Research has segmented the global agricultural biotechnology market on the basis of application, organism type, and region:

Agricultural Biotechnology Application Outlook (Revenue, USD Billion, 2014 - 2025)

• Vaccine Development
• Transgenic Crops & Animals
• Antibiotic Development
• Nutritional Supplements
• Flower Culturing
• Biofuels

Agricultural Biotechnology Organism Type Outlook (Revenue, USD Billion, 2014 - 2025)

• Plants
• Conventional Techniques
• Established Genetic Modification
• New Breeding Techniques
• Animals
• Conventional Techniques
• Established Genetic Modification
• New Breeding Techniques
• Microbes
• Conventional Techniques
• Established Genetic Modification
• New Breeding Techniques

Agricultural Biotechnology Regional Outlook (Revenue, USD Billion, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• MEA
• South Africa

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

U.S. Medical Thermometer Market Trends, Applications, Analysis, Growth, And Forecast 2027

The U.S. medical thermometer market size is expected to reach USD 653.0 million by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 28.7% over the forecast period. Increasing cases of COVID-19, malaria, influenza, and norovirus along with other medical conditions are driving the product demand for the assessment of precise body temperature.

In addition, growing demand for Non-contact Clinical Electronic Thermometers (NCITs) is expected to boost market growth. As compared to contact type thermometer, NCITs are more frequently used in various infectious diseases including COVID-19, as components of the contact type, clinical thermometer poses high risks of infection.

Moreover, the introduction of new products and incorporation of new technologies by market players are likely to boost the market growth during the forecast period. For instance, MicroLife is the first company to launch ‘Silent Glow Technology”, which shows red light if the temperature exceeds 37.4 degree Celsius.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/us-medical-thermometer-market

U.S. Medical Thermometer Market Report Highlights

• Based on devices, the market is segmented into mercury-based and mercury-free. Mercury-free was the leading device segment with a share of over 60.6% in 2019
• The segment is projected to retain its dominant position over the forecast years on account of to the benefits of these devices, such as accurate readings & low chances of cross-infection, as well as rising prevalence of diseases such as fever and flu
• The mercury-free segment is further divided into infrared radiation, digital, and other thermometers and is projected to expand at the fastest CAGR over the forecast period
• Some of the key players operating in the market are Medline Industries, Inc.; 3M; Welch Allyn; America Diagnostics Corp.; A&D Medical; Exergen Corporation, and MicroLife Corporation
• Market participants are trying to gain competitive advantage by providing technologically advanced products, such as Bluetooth-enabled thermometers and multifunctional NCITs
• For instance, in April 2020, Kinsa, Inc., distributed around 7,500 Bluetooth-enabled smart thermometers, which can pair up with smartphone apps and allow tracking of real-time COVID-19 hot spots across the U.S.

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/us-medical-thermometer-market/request/rs1

U.S. Medical Thermometer Market Segmentation

Grand View Research has segmented the U.S. medical thermometer market on the basis of device:

U.S. Medical Thermometer Device Outlook (Revenue, USD Million, 2016 - 2027)

• Mercury-free
• Infrared Radiation Thermometer
• Digital Thermometers
• Others
• Mercury-based

List of Key Players of U.S. Medical Thermometer Market

• America Diagnostics Corp.
• Easywell Biomedicals, Inc.
• Cardinal Health
• Compumedics Ltd.
• Terumo Corp.
• McKesson Corp.
• Medical Indicators, Inc.
• Mediaid, Inc.
• Medline Industries, Inc.
• 3M (Nexcare)
• Welch Allyn
• A&D Medical
• Exergen Corporation
• Microlife Corporation

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Blockchain Technology in Healthcare Market Trends, Applications, Analysis, Business Growth, And Forecast To 2026

The global blockchain technology in healthcare market size is expected to reach USD 11.5 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 63.9% during the forecast period. Increasing need to prevent drug counterfeit coupled with demand for efficient clinical data management is anticipated to drive the growth. Furthermore, technological advancements and untapped opportunities in the healthcare sector are some of the major factor leading to the adoption of the technology.

Blockchain technology has grown at a rapid pace in the past few years. The technology has been utilized by the big corporations for profit maximization and cost cutting. Many leading healthcare and life science companies including Pfizer Inc.; Amerisource Bergen Corporation; McKesson Corporation; and Premier Inc. have all recently joined blockchain-powered project MediLedger to tackle the inadequacies of supply chain. Reduction or elimination in frauds and errors, reduction in delays from paperwork, identification of issues rapidly, minimization of courier costs, improvement in inventory management, and increase in consumer and partner trust are some of the purported benefits of blockchain technology facilitating supply chain management.

Furthermore, the pharmaceutical industry is only one part of the overall healthcare ecosystem which is vigorously exploring the use cases of the blockchain and many of the ideas already have the proof-of-concept implementations. The technology holds ability to effectively improve the patient care while maintaining the funds at reasonable rate. The hindrances and challenges that arise in multiple level authentication can also be eliminated through the adoption of blockchain. Furthermore, with the growing adoption, the technology has made its way to healthcare sector. Even at its beginning and infancy stage, the technology is being accepted by the people and company in the healthcare ecosystem.

Clinical data exchange and interoperability segment of the blockchain technology in healthcare market is expected to expand at the considerable CAGR during the forecast period. Clinical data exchange and interoperability are currently the most vulnerable processes affected by a huge data breach and drug counterfeit. For Instance, according to the Health Research Funding Organization (HRFO), in 2017, nearly 10% to 30% of the drugs in emerging countries were not original, which represent a huge market of drug counterfeit. The U.S. healthcare industry, in 2017, bore a loss of about $200 billion annually, due to counterfeit issues.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/blockchain-technology-healthcare-market

Blockchain Technology in Healthcare Market Report Highlights

• Drug and medical device companies accounted for the largest market share in the end use segment in 2018
• Clinical data and e-consenting segment held over 26.0% market share in 2018.
• Private blockchain type segment is anticipated to witness the fastest growth due to supportive legislative policies in developed countries
• Europe held the leading market share of over 35.0% in 2018, attributed to increase in incidence of data breaches, supportive government policies, favorable reimbursement schemes, rise in awareness, and increase in number of training programs
• Key players operating in the blockchain in healthcare market include IBM Corporation; Microsoft; PokitDok, Inc.; Patientory, Inc.; GuardTime; Blockpharma; MedRec; iSolve, LLC; DeepMind Health; and Stratumn; among others.

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/blockchain-technology-healthcare-market/request/rs1

Blockchain Technology in Healthcare Market Segmentation

Grand View Research has segmented the global blockchain technology in healthcare market on the basis of the type, application, end use, and region:

Blockchain Technology in Healthcare Type Outlook (Revenue, USD Million, 2016 - 2026)

• Private
• Public

Blockchain Technology in Healthcare Application Outlook (Revenue, USD Million, 2016 - 2026)

• Clinical Data Exchange & Interoperability
• Claims Adjudication & Billing
• Supply Chain Management
• Clinical Trials and e-Consenting
• Others

Blockchain Technology in Healthcare End Use Outlook (Revenue, USD Million, 2016 - 2026)

• Hospitals
• Insurance Providers
• Drug and Medical Device Companies
• Others

Blockchain Technology in Healthcare Regional Outlook (Revenue, USD Million, 2016 - 2026)

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Switzerland
• Asia Pacific
• Japan
• China
• Australia
• India
• Singapore
• Latin America
• Mexico
• Brazil
• MEA
• South Africa
• UAE

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

U.S. Pharmaceutical Sterility Testing Market Trends, Applications, Analysis, Business Growth Analysis By 2025

The U.S. pharmaceutical sterility testing market size is expected to reach USD 713.6 million by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 11.3% over the forecast period. Supportive government investment in healthcare industry, increasing R&D activities, and drug launches are the key factors driving market growth.

The government is keen on bringing down healthcare costs which is anticipated to encourage the U.S. Food and Drug Administration (FDA) to promote fast approvals of generic pharmaceuticals. Faster approvals drive the need for newer sterility testing methods. This is anticipated to encourage market participants to spend more on sterility solutions and in turn, expand the market. With increasing demand for drugs, companies are launching newer drugs with different routes of administration, dosage, and indication. These launches require thorough sterility testing and thus, are anticipated to drive market growth.

On the basis of type, the U.S. pharmaceutical sterility testing market is segmented into in-house and outsourcing. Most market players prefer outsourcing sterility testing services, as it is economically viable. Companies shortlist and select outsourcing firms based on their experience, expertise, and quality of service. Hence, it is difficult for new players to enter into this area.

Companies active in the U.S. pharmaceutical sterility testing market are Charles River Laboratories, Pace Analytical Series LLC, DynaLabs, Infinity, Boston Analytical, and others. Market players employ various growth strategies such as mergers, capacity expansion, and venturing into new regions. For instance, in April 2018, Charles River Labs completed acquisition of MPI Research, a non-clinical Contract Research Organization (CRO) providing detailed services to medical device and biopharmaceutical companies. This acquisition is anticipated to expand biotechnology client base of the former and to provide the company access to MPI’s scientific expertise and quality services.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/us-pharmaceutical-sterility-testing-market

U.S. Pharmaceutical Sterility Testing Market Report Highlights

• U.S. pharmaceutical sterility testing market was valued at USD 302.2 million in 2017 and is expected to grow lucratively over the forecast period
• In terms of revenue, outsourcing segment is anticipated to grow at a lucrative rate during the forecast period.
• Sterility testing segment was valued at USD 97.6 million in 2016 and is anticipated to witness swift growth over the forecast period.

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/us-pharmaceutical-sterility-testing-market/request/rs1

U.S. Pharmaceutical Sterility Testing Market Segmentation

Grand View Research has segmented the U.S. pharmaceutical sterility testing market on the basis of type, test type, end use, and sample:

U.S. Pharmaceutical Sterility Testing by Type (Revenue, USD Million, 2014 - 2025)

• In-house
• Outsourced

U.S. Pharmaceutical Sterility Testing by Test Type (Revenue, USD Million, 2014 - 2025)

• Sterility Test
• Bioburden Testing
• Bacterial Endotoxin Test

U.S. Pharmaceutical Sterility Testing by End Use (Revenue, USD Million, 2014 - 2025)

• Compounding Pharmacies
• Medical Device Companies
• Pharmaceutical Companies
• Others

U.S. Pharmaceutical Sterility Testing by Sample (Revenue, USD Million, 2014 - 2025)

• Sterility Drugs
• Medical Devices
• Biologics & Therapies

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

U.S. Peripheral Vascular Devices And Accessories Market Business Growth, Development Factors, Applications, And Future Prospects 2027

The U.S. peripheral vascular devices and accessories market size is expected to reach USD 4.6 billion by 2027, according to a new report by Grand View Research, Inc. The market and is expected to expand at a CAGR of 4.5% from 2020 to 2027. Growing prevalence of venous diseases or Chronic Venous Insufficiency (CVI) is one of the key factors driving the growth of the market. Furthermore, growing geriatric population, and increasing demand for minimally invasive endovascular procedures is further increasing its adoption and bolstering revenue growth over the forecast period.

Based on product type, the peripheral vascular stents segment dominated the market in 2019. Factors contributing to the increase in demand include technological advancements in stent technology and increasing demand for minimally invasive procedures. In addition, the peripheral stent market is majorly driven by a growing patient pool requiring the immediate stent placement, technological innovations in peripheral vascular interventions, and growing number of government initiatives. These factors are further propelling the overall growth.

In 2019, based on the guidewire coating, the hydrophilic guidewire coating segment accounted for the largest revenue share. This growth is attributed to easy accessibility and more slippery nature when combined with water. Furthermore, factors such as reduction in friction and increase in trackability are expected to propel the growth of the market during the forecast period. In addition, this segment is expected to witness the highest CAGR owing to benefits such as tackling tortuous lesions and help in finding microchannels in occlusions. Moreover, increasing innovations and advancements by various players are expected to increase the adoption of guidewires with a hydrophilic coating. For instance, NaviPro guidewire, provided by Boston Scientific, is 100 percent hydrophilic guidewire useful for smooth passage through tortuous lesions or anatomy. Therefore, the advantages provided by hydrophilic guidewires and increasing number of innovative guidewires with hydrophilic coating are expected to promote growth over the forecast period.

Based on guidewire tip weight wire, extra support tip guidewires dominated the market with a revenue share of 41.1% in 2019. Torque movement, fine control, and support provided for treatment of complex and diffuse lesions are some of the key factors fueling market growth. In addition, these types of guidewires are also beneficial in providing support to the delivery of bulky devices. Furthermore, this segment is also expected to exhibit lucrative growth over the forecast period due to its use in the treatment and diagnosis of chronic occlusions, distal lesions, and tortuous anatomies. Hence, enhancement in steerability and flexibility of the guidewire due to higher tip load, availability of hydrophilic and hydrophobic variants and power of tackling complex lesions are some of the advantages boosting the adoption of extra support tip guidewires.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/us-peripheral-vascular-devices-accessories-market

U.S. Peripheral Vascular Devices And Accessories Market Report Highlights

• The market size is expected to reach USD 4.6 billion by 2027 owing to the growing prevalence of venous diseases or Chronic Venous Insufficiency (CVI), growing geriatric population, and increasing demand for minimally invasive endovascular procedures
• The peripheral vascular stents segment dominated the market in 2019. Factors contributing to the increase in demand include technological advancements in stent technology and increasing demand for minimally invasive procedures
• Based on guidewire coating, the hydrophilic guidewire coating segment accounted for the highest revenue share in 2019. This growth is attributed to easy accessibility and more slippery nature when combined with water
• Based on guidewire tip weight wire, extra support tip guidewires dominated the market with a revenue share of 41.1% in 2019. Torque movement, fine control, and support provided for treatment of complex and diffuse lesions are some of the key factors fueling segment growth

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/us-peripheral-vascular-devices-accessories-market/request/rs1

U.S. Peripheral Vascular Devices And Accessories Market Segmentation

Grand View Research has segmented the U.S. peripheral vascular devices and accessories market based on product, guidewire coating, and guidewire tip weight wire:

U.S. Peripheral Vascular Devices And Accessories Product Outlook (Volume, Units; Revenue, USD Million, 2016 - 2027)

• Peripheral Stents
• Carotid Artery Stents
• Renal Artery Stents
• Femoral Artery Stents
• Iliac Artery Stents
• Other Peripheral Stents
• PTA Balloons
• Catheters
• Angiography Catheters
• Guiding Catheters
• IVUS/OCT Catheters
• Peripheral Accessories
• Guidewires

• Workhorse Guidewires
• Frontline Finesse Guidewires
• Extra Support Guidewires
• Specialty Guidewires
• Peripheral Vascular Closure Devices
• Introducer Sheaths
• Balloon Inflation Devices

U.S. Peripheral Vascular Devices And Accessories Guidewire Coating Outlook (Volume, Units; Revenue, USD Million, 2016 - 2027)

• Hydrophilic Coating
• Hydrophobic Coating

U.S. Peripheral Vascular Devices And Accessories Guidewire Tip Weight Wire Outlook (Volume, Units; Revenue, USD Million, 2016 - 2027)

• Floppy Tip
• Balanced Tip
• Extra Support Tip

List of Key Players of U.S. Peripheral Vascular Devices And Accessories Market

• Abbott Laboratories
• Terumo Medical Corporation
• Medtronic, Inc.
• Boston Scientific Corporation
• Cordis
• Philips
• AngioDynamics, Inc.
• Asahi Intecc Co. Ltd.
• Becton Dickinson and Co
• BIOTRONIK
• Biosensors International Group
• B. Braun
• iVascular
• Merit Medical
• Cook Group Inc.

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com